Article

Alcon recalls microsurgical system

Alcon Laboratories is recalling a microsurgical system (Constellation Vision System) after identifying software and hardware issues associated with unexpected loss of power, unintended system error messages, unresponsive touch screens, and system setting and infusion performance problems.

Huenenberg, Switzerland-Alcon Laboratories is recalling a microsurgical system (Constellation Vision System) after identifying software and hardware issues associated with unexpected loss of power, unintended system error messages, unresponsive touch screens, and system setting and infusion performance problems. According to the FDA, these events may cause eye injuries, including blindness.

All models and catalog numbers are affected by this recall and are listed in the agency’s recall notice. These devices were manufactured and distributed between Sept. 1, 2008, and April 30, 2010.

The agency recommends that adverse events and side effects be reported to its MedWatch Safety Information and Adverse Event Reporting Program. The Web site for the program is www.fda.gov/MedWatch/report.htm; the telephone number is 800/332-1088; and the fax number is 800/FDA-0178. Also, a postage-paid FDA form 3500 may be downloaded from the MedWatch “Download Forms” page and sent to the address on the pre-addressed form.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.